Should I buy Sherwin-Williams (SHW) stock or is it too late?

Sherwin-Williams · Materials · price $324

See the full Sherwin-Williams (SHW) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 63% of its targets hit on this sector (185 calls tested). It aims for $363 (+12 %), call made on October 6, 2026, maturing on October 6, 2027 (8 d ago).

The 5 reliable analysts $392+21 %

The 7 other firms $380+17 %

How to read it: the 5 reliable firms are not filtered by optimism — 5 aim above the price, 0 below, hence their $392 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Sherwin-Williams

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
JP Morgan	82 %	+20.9 %	11	$380 +17%
Citigroup	76 %	+20.1 %	17	$380 +17%
Morgan Stanley	71 %	+16.5 %	21	$395 +22%
Mizuho	83 %	+13.9 %	12	$371 +14%
Loop Capital	70 %	+13.1 %	10	$380 +17%
Wells Fargo	50 %	+10.2 %	14	$340 +5%
Evercore ISI Group	45 %	+8.7 %	11	$400 +23%
RBC Capital	52 %	+5.8 %	21	$392 +21%

In short — Should you invest in Sherwin-Williams? Is it too late, still worth it? Analysts are fairly positive (62% buy, median target $392, i.e. +21%), and the most reliable on SHW targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

62% of analysts rate it a buy (Buy consensus, 13 ratings) — a sign of market conviction.
Median price target $392, i.e. +21% from the current price ($324).
The most reliable firm on SHW, Mizuho (83% hit rate, 12 scored calls), targets $371 (call made on March 23, 2026, maturing on March 23, 2027) (+14%) in its most recent call, and $390 (call made on December 18, 2025, maturing on December 18, 2026) (+20%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 13 ratings, 5 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on SHW

Median target $392 (+21%) · 13 ratings · Buy consensus

Strong Buy00%

Buy862%

Hold538%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Sherwin-Williams now?

We won't decide for you. The facts: 62% of analysts rate it a buy, median target $392 (+21%), and Mizuho (most reliable on SHW, 83%) targets $371. Weigh that against valuation (P/E ~30). This is not personalized advice.

Is it too late to invest in Sherwin-Williams?

Not according to analysts: the median target ($392) is still +21% above the current price ($324) (most reliable on SHW: Mizuho, 83%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Sherwin-Williams still worth investing in?

It depends on the gap between the price ($324) and its estimated value: analysts target $392 on median (+21%), with 62% buys (most reliable on SHW: Mizuho, 83%). Cross-check with their real reliability on SHW and the cautions above. Information, not advice.

What's the main risk in buying SHW?

The consensus is not unanimous: of 13 ratings, 5 are neutral.

→ Go deeper: the full Sherwin-Williams profile (consensus, analyst reliability, price target, performance).